Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Gastric”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01095120
What this trial is testing

Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer

Who this might be right for
Adenocarcinoma of the StomachAdenocarcinoma of Esophagogastric Junction
Genta Incorporated 27
Testing effectiveness (Phase 2)Looking for participantsNCT06503146
What this trial is testing

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

Who this might be right for
SarcomaSmall Cell Lung Cancer or Extrapulmonary Neuroendocrine Cancer (EP-NEC)Mesothelioma+7 more
National Cancer Institute (NCI) 320
Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Testing effectiveness (Phase 2)Study completedNCT00517829
What this trial is testing

Docetaxel+Oxali+/-Cetux Met Gastric/GEJ

Who this might be right for
Gastric Cancer Adenocarcinoma Metastatic
US Oncology Research 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07772557
What this trial is testing

Adjuvant Therapy for Potentially Immunotherapy-Responsive Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 108
Testing effectiveness (Phase 2)UnknownNCT03030937
What this trial is testing

Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA

Who this might be right for
Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction
Fujian Cancer Hospital 74
Large-scale testing (Phase 3)Ended earlyNCT01697072
What this trial is testing

First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Who this might be right for
Gastric Cancer
Amgen 609
Testing effectiveness (Phase 2)Looking for participantsNCT05687357
What this trial is testing

Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma

Who this might be right for
Gastric CancerGastroesophageal-junction Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 140
Not applicableActive Not RecruitingNCT04878783
What this trial is testing

Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRG

Who this might be right for
Gastric CancerAdenocarcinoma of the Stomach
University of Roma La Sapienza 138
Testing effectiveness (Phase 2)Study completedNCT05641896
What this trial is testing

Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers

Who this might be right for
Gastrointestinal CancersCholangiocarcinomaGastric Cancer+3 more
SOFIE 109
Large-scale testing (Phase 3)UnknownNCT02512380
What this trial is testing

Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer

Who this might be right for
Gastric Adenocarcinoma
Chinese Academy of Medical Sciences 380
Large-scale testing (Phase 3)Looking for participantsNCT05477576
What this trial is testing

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

Who this might be right for
GEP-NETGastroenteropancreatic Neuroendocrine TumorGastroenteropancreatic Neuroendocrine Tumor Disease+4 more
RayzeBio, Inc. 338
Testing effectiveness (Phase 2)Looking for participantsNCT04325425
What this trial is testing

Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary

Who this might be right for
Neuroendocrine Carcinoma
Centre Hospitalier Universitaire Dijon 218
Early research (Phase 1)Looking for participantsNCT06657144
What this trial is testing

CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Coherus Oncology, Inc. 154
Not applicableLooking for participantsNCT03823144
What this trial is testing

Intravital Microscopy in Human Solid Tumors

Who this might be right for
Solid Tumor, AdultClinical Stage IV Gastric Cancer AJCC v8Malignant Solid Neoplasm+20 more
Mayo Clinic 85
Early research (Phase 1)Active Not RecruitingNCT03833700
What this trial is testing

E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

Who this might be right for
Solid NeoplasmsColorectal NeoplasmsGastrointestinal Tumors
Eisai Co., Ltd. 70
Early research (Phase 1)WithdrawnNCT03682744
What this trial is testing

CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+4 more
Sorrento Therapeutics, Inc.
Not applicableStudy completedNCT04192734
What this trial is testing

Retrospective Study of Ramucirumab and Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction Adenocarcinoma
Hallym University Medical Center 1,063
Not applicableUnknownNCT05816863
What this trial is testing

Clinical Study of Pabolizumab for Neoadjuvant Immunotherapy of Locally Advanced Microsatellite-unstable Gastric Adenocarcinoma

Who this might be right for
Gastric CancerGastric Adenocarcinoma
Peking University Cancer Hospital & Institute 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06238167
What this trial is testing

Tislelizumab Plus Chemotherapy as Postoperative Adjuvant Therapy in Elderly Patients With LA GC/GEJC

Who this might be right for
Gastric Cancer
First Affiliated Hospital of Wenzhou Medical University 40
Next Page